Cargando…

How to mathematically optimize drug regimens using optimal control

This article gives an overview of a technique called optimal control, which is used to optimize real-world quantities represented by mathematical models. I include background information about the historical development of the technique and applications in a variety of fields. The main focus here is...

Descripción completa

Detalles Bibliográficos
Autor principal: Moore, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847021/
https://www.ncbi.nlm.nih.gov/pubmed/29411198
http://dx.doi.org/10.1007/s10928-018-9568-y
_version_ 1783305670064340992
author Moore, Helen
author_facet Moore, Helen
author_sort Moore, Helen
collection PubMed
description This article gives an overview of a technique called optimal control, which is used to optimize real-world quantities represented by mathematical models. I include background information about the historical development of the technique and applications in a variety of fields. The main focus here is the application to diseases and therapies, particularly the optimization of combination therapies, and I highlight several such examples. I also describe the basic theory of optimal control, and illustrate each of the steps with an example that optimizes the doses in a combination regimen for leukemia. References are provided for more complex cases. The article is aimed at modelers working in drug development, who have not used optimal control previously. My goal is to make this technique more accessible in the biopharma community.
format Online
Article
Text
id pubmed-5847021
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-58470212018-03-20 How to mathematically optimize drug regimens using optimal control Moore, Helen J Pharmacokinet Pharmacodyn Original Paper This article gives an overview of a technique called optimal control, which is used to optimize real-world quantities represented by mathematical models. I include background information about the historical development of the technique and applications in a variety of fields. The main focus here is the application to diseases and therapies, particularly the optimization of combination therapies, and I highlight several such examples. I also describe the basic theory of optimal control, and illustrate each of the steps with an example that optimizes the doses in a combination regimen for leukemia. References are provided for more complex cases. The article is aimed at modelers working in drug development, who have not used optimal control previously. My goal is to make this technique more accessible in the biopharma community. Springer US 2018-02-06 2018 /pmc/articles/PMC5847021/ /pubmed/29411198 http://dx.doi.org/10.1007/s10928-018-9568-y Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Paper
Moore, Helen
How to mathematically optimize drug regimens using optimal control
title How to mathematically optimize drug regimens using optimal control
title_full How to mathematically optimize drug regimens using optimal control
title_fullStr How to mathematically optimize drug regimens using optimal control
title_full_unstemmed How to mathematically optimize drug regimens using optimal control
title_short How to mathematically optimize drug regimens using optimal control
title_sort how to mathematically optimize drug regimens using optimal control
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847021/
https://www.ncbi.nlm.nih.gov/pubmed/29411198
http://dx.doi.org/10.1007/s10928-018-9568-y
work_keys_str_mv AT moorehelen howtomathematicallyoptimizedrugregimensusingoptimalcontrol